Pills in a bottle/Credit: coffeehuman/Shutterstock.com
The average prices of top-selling drugs used by Medicare enrollees have tripled in cost since coming on the market, a new report from AARP has found. List prices for these drugs have increased by an average of 226%, rising at a considerably higher rate than inflation, and AARP officials said this reflected a general trend in the pharmaceutical industry. The report also points to recently passed legislation that allows Medicare to negotiate drug prices in an effort to moderate rising drug costs for both Medicare enrollees and those in private health plans.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
